The vitamin D3 analogue calcipotriol used in treating psoriasis inhibited IL-23/IL-17 axis and neutrophil infiltration in psoriatic skin through the vitamin D receptor (VDR) in keratinocytes [41]. Here, IL17A is linked to psoriasis.